BiomeSense
Private Company
Total funding raised: $15.1M
Overview
BiomeSense is a microbiome data infrastructure company building a proprietary platform to generate and analyze continuous, high-resolution gut microbiome data. The company's technology integrates the GutLab system for at-home sample collection and the MetaBiome AI platform for advanced time-series analysis, targeting the limitations of current costly and sparse microbiome sampling. BiomeSense partners with research institutions and biopharma companies to support exploratory research, biomarker discovery, and product development in the microbiome space, positioning the gut microbiome as a next frontier in precision medicine.
Technology Platform
Integrated platform combining GutLab (hardware for continuous, at-home microbiome sample collection) and MetaBiome (AI-enabled bioinformatics platform for longitudinal time-series analysis of microbiome data).
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competition includes large sequencing service providers (e.g., Illumina, Qiagen), contract research organizations (CROs) offering microbiome analysis, and other startups focused on microbiome sampling or AI analytics. BiomeSense differentiates through its integrated focus on continuous, longitudinal data capture and specialized time-series AI.